Limited Data to Evaluate Real‐World Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Journal of Inherited Metabolic Disease - Netherlands
doi 10.1002/jimd.12103
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Wiley

Related search

Mucopolysaccharidosis Type II: Enzyme Replacement Therapy Efficiency

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2020English

Immune Response to Intrathecal Enzyme Replacement Therapy in Mucopolysaccharidosis I Patients

Pediatric Research
Child HealthPediatricsPerinatology
2013English

Enzyme Replacement Therapy Treatment From Birth Increases Therapeutic Efficacy and Generates Tolerance to Enzyme in Canine Mucopolysaccharidosis Type I

English

Pharmacoeconomic Evaluation of Drugs Used in Enzyme Replacement Therapy Mucopolysaccharidosis Type II

Pharmacoeconomics: theory and practice
2019English

Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019English

Pcp53 - A Diagnostic Framework to Evaluate Real-World Data Sources for Real-World Evidence Generation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Monitoring Dose Response of Enzyme Replacement Therapy in Feline Mucopolysaccharidosis Type VI by Tandem Mass Spectrometry

Pediatric Research
Child HealthPediatricsPerinatology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy